Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin

Int J Hematol. 2022 Dec;116(6):973-975. doi: 10.1007/s12185-022-03477-8. Epub 2022 Oct 29.

Takahito Iwai^{1

2}, Mutsumi Nishida³, Junichi Sugita^{1

4}, Atsushi Yasumoto^{1

4}, Yuta Hasegawa^{1

4}, Tomoko Morimoto⁵, Daishi Nakayama⁶, Kohei Okada⁷, Akio Mori⁸, Takanori Teshima^{1

2

4}

¹ Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
² Diagnostic Center for Sonography, Hokkaido University Hospital, N14 W5, Kita-Ku, Sapporo, 060-8648, Japan.
³ Diagnostic Center for Sonography, Hokkaido University Hospital, N14 W5, Kita-Ku, Sapporo, 060-8648, Japan. [email protected].
⁴ Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
⁵ Medical Technology Sector, Aiiku Hospital, Sapporo, Japan.
⁶ Department of Radiology, Sapporo Hokuyu Hospital, Sapporo, Japan.
⁷ Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
⁸ Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.

No abstract available

Publication types